Biotechnology

Biotech Facility Design, Engineering, and Construction Services

Seamlessly adopt new processes and produce higher quality therapeutics faster.

Stay ahead of the rapidly evolving biotechnology industry with a flexible facility and expertly designed process systems. Readily adapt to new advances while producing the best quality drug products quickly and cost-effectively.

The biotech industry doesn’t just rely on us for engineering, consulting and construction knowledge; biotech leaders come to CRB for expertise in industry trends and technologies.

Push the boundaries of facility design and construction for the future of medicine manufacturing. Work with a team that’s pioneering processes and facilities to produce complex biological products.

The future
of medicine
now

Build from nothing, expand your facility or improve your current process. Get a custom, best-in-class solution.

What’s the next step? Tell us more about your project.

What we do:

Cell + Gene Therapy

Vaccines

RNA Therapies

Next generation therapies now.

Achieve a facility that is flexible enough to continuously adopt technology which doesn’t yet exist, resilient enough to support rapid scale-up to commercialization, and advanced enough to keep you at the front of the race toward breakthrough autologous and allogeneic cell and gene therapies.

Save lives. Manufacture effective vaccines quickly.

Whether you need one compliant process that maximizes throughput or a configurable facility that can accommodate multiple operating scenarios, get a solution that checks all the boxes.

Flexible RNA therapy facilities for a rapidly advancing sector.

Lead the way for this revolutionary technology with design and construction solutions that right-size your process, help you navigate a complex regulatory environment, and create a flexible facility that can adapt with the industry and your organization.

HORIZONS

Horizons: Life Sciences

Our latest report, built on the insights of more than 500 life science industry leaders, explores the evolving science and business of drug manufacturing and the operational shifts our industry must make, especially as COVID-19 has changed our work and our world.

Download the Report